Gary E. Hood is a shareholder in the Chicago office of Polsinelli PC. He is the Chair of the Firm’s Intellectual Property Proceedings and Litigation Division, and is also the Chair of the firm’s Hatch-Waxman Group. Gary’s over 20 years of courtroom experience trying cases involving a range of legal issues have given him perspective and insight on judge and jury persuasion for which clients seek him out. He developed and employs a unique case preparation method that identifies strategic direction early, and avoids the conventional "no stone unturned" approach that often drives fees.
Gary has experience in a broad array of civil and criminal matters. He now focuses his practice on intellectual property litigation including Hatch-Waxman matters, and regularly appears in courtrooms throughout the United States litigating a variety of pharmaceutical patent cases. Gary has been named a Chicago Leading Lawyer in various areas of intellectual property law from 2013-2017. He has been named in the Intellectual Asset Management IAM Patent 1000 as recommended for patent litigation in Illinois in each of 2014-2017, and honored by Managing Intellectual Property magazine as an IP Star each year since 2013. He writes and speaks frequently at various conferences and seminars on topics related to intellectual property, including in the pharmaceuticals and biotech industries.
Gary graduated magna cum laude from Gonzaga University School of Law, where he served as Editor-in-Chief of the Gonzaga Law Review and on the regional champion and national qualifying National Moot Court Team. Gary earned his bachelor of science degree in electrical engineering from the University of Southern California. He is a lifelong competitive swimmer, as well as a former United States Naval Officer. He is the recipient of a number of military medals and awards for his service to the country including during Operation Desert Storm.
Key IP Areas
- Trade Mark
- Food & Beverage
- Information Science inc Technology + Communications
- Medical Devices
- Pharmaceuticals inc Biotechnology + Life Sciences
Last updated 12th April 2018